{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T11:20:02Z","timestamp":1787916002128,"version":"build-2784847793"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T00:00:00Z","timestamp":1787875200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T00:00:00Z","timestamp":1787875200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1007\/s11033-026-12624-x","type":"journal-article","created":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T11:10:49Z","timestamp":1787915449000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Dysregulation of circ-SMARCA5, circ-RHOT1, and HNF1A and the association of HNF1A polymorphisms with hepatocellular carcinoma"],"prefix":"10.1007","volume":"53","author":[{"given":"Basma A.","family":"Ibrahim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Basma S.","family":"Elsayed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed Abdelaziz","family":"Gendia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manar","family":"Moustafa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ansam M. Z.","family":"El Desoky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,28]]},"reference":[{"issue":"12","key":"12624_CR1","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1038\/s41571-023-00825-3","volume":"20","author":"AG Singal","year":"2023","unstructured":"Singal AG, Kanwal F, Llovet JM (2023) Global trends in hepatocellular carcinoma epidemiology: implications for screening, prevention and therapy. Nat Rev Clin Oncol 20(12):864\u2013884. https:\/\/doi.org\/10.1038\/s41571-023-00825-3","journal-title":"Nat Rev Clin Oncol"},{"issue":"4","key":"12624_CR2","doi-asserted-by":"publisher","first-page":"879","DOI":"10.21608\/jbaar.2024.393371","volume":"10","author":"A Yameny","year":"2024","unstructured":"Yameny A (2024) Hepatocellular carcinoma (HCC) in Egypt: Prevalence, risk factors, diagnosis and prevention: A Review. J Bioscience Appl Res 10(4):879\u2013890. https:\/\/doi.org\/10.21608\/jbaar.2024.393371","journal-title":"J Bioscience Appl Res"},{"issue":"2","key":"12624_CR3","doi-asserted-by":"publisher","first-page":"102446","DOI":"10.1016\/j.jceh.2024.102446","volume":"15","author":"SP Singh","year":"2025","unstructured":"Singh SP, Madke T, Chand P (2025) Global Epidemiology of Hepatocellular Carcinoma. J Clin Exp Hepatol 15(2):102446. https:\/\/doi.org\/10.1016\/j.jceh.2024.102446","journal-title":"J Clin Exp Hepatol"},{"issue":"6","key":"12624_CR4","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1515\/jtim-2024-0020","volume":"12","author":"Q Shi","year":"2025","unstructured":"Shi Q, Jiang S, Zeng Y et al (2025) A Notch signaling pathway-related gene signature: Characterizing the immune microenvironment and predicting prognosis in hepatocellular carcinoma. J Transl Int Med 12(6):553\u2013568 Published 2025 Jan 10. https:\/\/doi.org\/10.1515\/jtim-2024-0020","journal-title":"J Transl Int Med"},{"issue":"5","key":"12624_CR5","doi-asserted-by":"publisher","first-page":"e101022209750","DOI":"10.2174\/1874467215666221010092825","volume":"16","author":"NM Abdel-Hamid","year":"2023","unstructured":"Abdel-Hamid NM, Al-Quzweny RM (2023) Prevalence of hepatocellular carcinoma in men and the contribution of androgen and its receptor in pathogenesis and therapy. Curr Mol Pharmacol 16(5):e101022209750. https:\/\/doi.org\/10.2174\/1874467215666221010092825","journal-title":"Curr Mol Pharmacol"},{"key":"12624_CR6","doi-asserted-by":"publisher","first-page":"e18761429358008","DOI":"10.2174\/0118761429358008250305070518","volume":"17","author":"W Xu","year":"2024","unstructured":"Xu W, Liao S, Hu Y, Huang Y, Zhou J (2024) Upregulation of miR-3130-5p enhances hepatocellular carcinoma growth by suppressing ferredoxin 1. Curr Mol Pharmacol 17:e18761429358008. https:\/\/doi.org\/10.2174\/0118761429358008250305070518","journal-title":"Curr Mol Pharmacol"},{"issue":"6","key":"12624_CR7","doi-asserted-by":"publisher","first-page":"975","DOI":"10.7150\/ijms.71840","volume":"19","author":"X Zhao","year":"2022","unstructured":"Zhao X, Zhong Y, Wang X, Shen J, An W (2022) Advances in Circular RNA and Its Applications. Int J Med Sci 19(6):975\u2013985. https:\/\/doi.org\/10.7150\/ijms.71840","journal-title":"Int J Med Sci"},{"issue":"12","key":"12624_CR8","doi-asserted-by":"publisher","first-page":"1503","DOI":"10.3390\/biom14121503","volume":"14","author":"F Xu","year":"2024","unstructured":"Xu F, Xiao Q, Du WW, Wang S, Yang BB (2024) CircRNA: Functions, Applications and Prospects. Biomolecules 14(12):1503. https:\/\/doi.org\/10.3390\/biom14121503","journal-title":"Biomolecules"},{"issue":"11","key":"12624_CR9","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1038\/s41419-024-07117-3","volume":"15","author":"S Li","year":"2024","unstructured":"Li S, Xiong S, Li Z, Yang L, Yang H, Xiong J, Pan W, Guo J, Xu S, Fu B (2024) USP3 promotes DNA damage response and chemotherapy resistance through stabilizing and deubiquitinating SMARCA5 in prostate cancer. Cell Death Dis 15(11):790. https:\/\/doi.org\/10.1038\/s41419-024-07117-3","journal-title":"Cell Death Dis"},{"issue":"5","key":"12624_CR10","doi-asserted-by":"publisher","first-page":"808","DOI":"10.3390\/cells11050808","volume":"11","author":"S Thakur","year":"2022","unstructured":"Thakur S, Cahais V, Turkova T, Zikmund T, Renard C, Stopka T, Korenjak M, Zavadil J (2022) Chromatin Remodeler Smarca5 Is Required for Cancer-Related Processes of Primary Cell Fitness and Immortalization. Cells 11(5):808. https:\/\/doi.org\/10.3390\/cells11050808","journal-title":"Cells"},{"issue":"1","key":"12624_CR11","doi-asserted-by":"publisher","first-page":"13308","DOI":"10.1038\/s41598-023-40358-4","volume":"13","author":"NA Hussein","year":"2023","unstructured":"Hussein NA, El Sewedy SM, Zakareya MM, Youssef EA, Ibrahim FAR (2023) Expression status of circ-SMARCA5, circ-NOL10, circ-LDLRAD3, and circ-RHOT1 in patients with colorectal cancer. Sci Rep 13(1):13308. https:\/\/doi.org\/10.1038\/s41598-023-40358-4","journal-title":"Sci Rep"},{"issue":"4","key":"12624_CR12","doi-asserted-by":"publisher","first-page":"45","DOI":"10.3892\/ijo.2023.5493","volume":"62","author":"R Xia","year":"2023","unstructured":"Xia R, Hu C, Ye Y, Zhang X, Li T, He R, Zheng S, Wen X, Chen R (2023) HNF1A regulates oxaliplatin resistance in pancreatic cancer by targeting 53BP1. Int J Oncol 62(4):45. https:\/\/doi.org\/10.3892\/ijo.2023.5493","journal-title":"Int J Oncol"},{"issue":"3","key":"12624_CR13","doi-asserted-by":"publisher","first-page":"300060521997326","DOI":"10.1177\/0300060521997326","volume":"49","author":"E Zhang","year":"2021","unstructured":"Zhang E, Huang X, He J (2021a) Integrated bioinformatic analysis of HNF1A in human cancers. J Int Med Res 49(3):300060521997326. https:\/\/doi.org\/10.1177\/0300060521997326","journal-title":"J Int Med Res"},{"issue":"1","key":"12624_CR14","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1186\/s12943-018-0813-1","volume":"17","author":"CH Ding","year":"2018","unstructured":"Ding CH, Yin C, Chen SJ, Wen LZ, Ding K, Lei SJ, Liu JP, Wang J, Chen KX, Jiang HL, Zhang X, Luo C, Xie WF (2018) The HNF1\u03b1-regulated lncRNA HNF1A-AS1 reverses the malignancy of hepatocellular carcinoma by enhancing the phosphatase activity of SHP-1. Mol Cancer 17(1):63. https:\/\/doi.org\/10.1186\/s12943-018-0813-1","journal-title":"Mol Cancer"},{"issue":"2","key":"12624_CR15","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1038\/s41422-018-0111-x","volume":"29","author":"Z Cheng","year":"2019","unstructured":"Cheng Z, He Z, Cai Y, Zhang C, Fu G, Li H, Sun W, Liu C, Cui X, Ning B, Xiang D, Zhou T, Li X, Xie W, Wang H, Ding J (2019) Conversion of hepatoma cells to hepatocyte-like cells by defined hepatocyte nuclear factors. Cell Res 29(2):124\u2013135. https:\/\/doi.org\/10.1038\/s41422-018-0111-x","journal-title":"Cell Res"},{"issue":"4","key":"12624_CR16","doi-asserted-by":"publisher","first-page":"1411","DOI":"10.31557\/APJCP.2024.25.4.1411","volume":"25","author":"HM Bedair","year":"2024","unstructured":"Bedair HM, El-Banna EA, Ahmed EA, Elhelbawy MG, Abdelfattah A, Khalaf FA, Abdel-Samiee M, El Sharnoby A (2024a) Evaluation of Circular RNA SMARCA5 as a Novel Biomarker for Hepatocellular Carcinoma. Asian Pac J Cancer Prev 25(4):1411\u20131417. https:\/\/doi.org\/10.31557\/APJCP.2024.25.4.1411","journal-title":"Asian Pac J Cancer Prev"},{"issue":"1","key":"12624_CR17","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1186\/s12943-019-1046-7","volume":"18","author":"L Wang","year":"2019","unstructured":"Wang L, Long H, Zheng Q, Bo X, Xiao X, Li B, Circular (2019) RNA circRHOT1 promotes hepatocellular carcinoma progression by initiation of NR2F6 expression. Mol Cancer 18(1):119. https:\/\/doi.org\/10.1186\/s12943-019-1046-7","journal-title":"Mol Cancer"},{"issue":"3","key":"12624_CR18","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1534\/genetics.104.92940","volume":"179","author":"AWGH Edwards","year":"2008","unstructured":"Edwards AWGH (2008) Hardy (1908) and Hardy-Weinberg equilibrium. Genetics 179(3):1143\u20131150. https:\/\/doi.org\/10.1534\/genetics.104.92940","journal-title":"Genetics"},{"key":"12624_CR19","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.ejca.2021.11.023","volume":"161","author":"H Rumgay","year":"2022","unstructured":"Rumgay H, Ferlay J, de Martel C, Georges D, Ibrahim AS, Zheng R, Wei W, Lemmens VEPP, Soerjomataram I (2022) Global, regional and national burden of primary liver cancer by subtype. Eur J Cancer 161:108\u2013118. https:\/\/doi.org\/10.1016\/j.ejca.2021.11.023","journal-title":"Eur J Cancer"},{"issue":"18","key":"12624_CR20","doi-asserted-by":"publisher","first-page":"6273","DOI":"10.1002\/cam4.4166","volume":"10","author":"M Verma","year":"2021","unstructured":"Verma M, Paik JM, Younossi I, Tan D, Abdelaal H, Younossi ZM (2021) The impact of hepatocellular carcinoma diagnosis on patients\u2019 health-related quality of life. Cancer Med 10(18):6273\u20136281. https:\/\/doi.org\/10.1002\/cam4.4166","journal-title":"Cancer Med"},{"key":"12624_CR21","doi-asserted-by":"publisher","unstructured":"Nagam LS, Vadde R, Jinka R (2022) Chapter 9 - Polymorphisms in hepatocellular carcinoma. Theranostics and Precision Medicine for the Management of Hepatocellular Carcinoma. Academic, pp 125\u2013133. https:\/\/doi.org\/10.1016\/B978-0-323-98806-3.00013-1.","DOI":"10.1016\/B978-0-323-98806-3.00013-1"},{"issue":"1\u20132","key":"12624_CR22","doi-asserted-by":"publisher","first-page":"e2941","DOI":"10.1002\/jgm.2941","volume":"19","author":"YJ Zhou","year":"2017","unstructured":"Zhou YJ, Yin RX, Hong SC, Yang Q, Cao XL, Chen WX (2017) Association of the HNF1A polymorphisms and serum lipid traits, the risk of coronary artery disease and ischemic stroke. J Gene Med 19(1\u20132):e2941. https:\/\/doi.org\/10.1002\/jgm.2941","journal-title":"J Gene Med"},{"issue":"2","key":"12624_CR23","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1210\/clinem\/dgae602","volume":"110","author":"C Yang","year":"2025","unstructured":"Yang C, Ji L, Han X (2025) Low C-Reactive Protein Alleles in Hepatocyte Nuclear Factor 1A Are Associated With an Increased Risk of Cardiovascular Disease. J Clin Endocrinol Metab 110(2):592\u2013600. https:\/\/doi.org\/10.1210\/clinem\/dgae602","journal-title":"J Clin Endocrinol Metab"},{"key":"12624_CR24","doi-asserted-by":"publisher","first-page":"e33947","DOI":"10.7554\/eLife.33947","volume":"7","author":"EV Abel","year":"2018","unstructured":"Abel EV, Goto M, Magnuson B, Abraham S, Ramanathan N, Hotaling E, Alaniz AA, Kumar-Sinha C, Dziubinski ML, Urs S, Wang L, Shi J, Waghray M, Ljungman M, Crawford HC, Simeone DM (2018) HNF1A is a novel oncogene that regulates human pancreatic cancer stem cell properties. Elife 7:e33947. https:\/\/doi.org\/10.7554\/eLife.33947","journal-title":"Elife"},{"key":"12624_CR25","doi-asserted-by":"publisher","first-page":"829565","DOI":"10.3389\/fendo.2022.829565","volume":"13","author":"LM Li","year":"2022","unstructured":"Li LM, Jiang BG, Sun LL (2022) HNF1A: From Monogenic Diabetes to Type 2 Diabetes and Gestational Diabetes Mellitus. Front Endocrinol (Lausanne) 13:829565. https:\/\/doi.org\/10.3389\/fendo.2022.829565","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"1","key":"12624_CR26","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/s13098-022-00794-0","volume":"14","author":"H Dallali","year":"2022","unstructured":"Dallali H, Hechmi M, Morjane I, Elouej S, Jmel H, Ben Halima Y, Abid A, Bahlous A, Barakat A, Jamoussi H, Abdelhak S, Kefi R (2022) Association of HNF1A gene variants and haplotypes with metabolic syndrome: a case-control study in the Tunisian population and a meta-analysis. Diabetol Metab Syndr 14(1):25. https:\/\/doi.org\/10.1186\/s13098-022-00794-0","journal-title":"Diabetol Metab Syndr"},{"key":"12624_CR27","doi-asserted-by":"publisher","first-page":"6273497","DOI":"10.1155\/2019\/6273497","volume":"2019","author":"XJ Li","year":"2019","unstructured":"Li XJ, Shao DH, He ML, Liang GW (2019a) Association of Common Variants in HNF1A Gene with Serum AFP Level in Healthy Chinese Individuals and HCC Patients. Dis Markers 2019:6273497. https:\/\/doi.org\/10.1155\/2019\/6273497","journal-title":"Dis Markers"},{"issue":"1","key":"12624_CR28","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1186\/s43066-024-00392-x","volume":"14","author":"HM Bedair","year":"2024","unstructured":"Bedair HM, Sayed IETE, Hendy OM, Abdel-Samiee M, Sayad IAEHE, Mandour SS (2024b) The hepatocyte nuclear factor 1 homeobox A (HNF1A) gene polymorphism and AFP serum levels in Egyptian HCC patients. Egypt Liver J 14(1):89. https:\/\/doi.org\/10.1186\/s43066-024-00392-x","journal-title":"Egypt Liver J"},{"issue":"3","key":"12624_CR29","doi-asserted-by":"publisher","first-page":"102286","DOI":"10.1016\/j.omtn.2024.102286","volume":"35","author":"I Kundu","year":"2024","unstructured":"Kundu I, Varshney S, Karnati S, Naidu S (2024) The multifaceted roles of circular RNAs in cancer hallmarks: From mechanisms to clinical implications. Mol Ther Nucleic Acids 35(3):102286. https:\/\/doi.org\/10.1016\/j.omtn.2024.102286","journal-title":"Mol Ther Nucleic Acids"},{"issue":"19","key":"12624_CR30","doi-asserted-by":"publisher","first-page":"3074","DOI":"10.3390\/cells11193074","volume":"11","author":"C Xue","year":"2022","unstructured":"Xue C, Wei J, Li M, Chen S, Zheng L, Zhan Y, Duan Y, Deng H, Xiong W, Li G, Li H, Zhou M (2022) The Emerging Roles and Clinical Potential of circSMARCA5 in Cancer. Cells 11(19):3074. https:\/\/doi.org\/10.3390\/cells11193074","journal-title":"Cells"},{"issue":"6","key":"12624_CR31","doi-asserted-by":"publisher","first-page":"1214","DOI":"10.1016\/j.jhep.2018.01.012","volume":"68","author":"J Yu","year":"2018","unstructured":"Yu J, Xu QG, Wang ZG, Yang Y, Zhang L, Ma JZ, Sun SH, Yang F, Zhou WP (2018) Circular RNA cSMARCA5 inhibits growth and metastasis in hepatocellular carcinoma. J Hepatol 68(6):1214\u20131227. https:\/\/doi.org\/10.1016\/j.jhep.2018.01.012","journal-title":"J Hepatol"},{"key":"12624_CR32","doi-asserted-by":"publisher","unstructured":"Zhang X, Zhou H, Jing W, Luo P, Qiu S, Liu X, Zhu M, Liang C, Yu M, Tu J (2018) The Circular RNA hsa_circ_0001445 Regulates the Proliferation and Migration of Hepatocellular Carcinoma and May Serve as a Diagnostic Biomarker. Dis Markers 3073467. https:\/\/doi.org\/10.1155\/2018\/3073467","DOI":"10.1155\/2018\/3073467"},{"key":"12624_CR33","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.cca.2019.02.001","volume":"492","author":"Z Li","year":"2019","unstructured":"Li Z, Zhou Y, Yang G, He S, Qiu X, Zhang L, Deng Q, Zheng F (2019b) Using circular RNA SMARCA5 as a potential novel biomarker for hepatocellular carcinoma. Clin Chim Acta 492:37\u201344. https:\/\/doi.org\/10.1016\/j.cca.2019.02.001","journal-title":"Clin Chim Acta"},{"issue":"12","key":"12624_CR34","doi-asserted-by":"publisher","first-page":"2735","DOI":"10.1007\/s10529-020-02985-z","volume":"42","author":"Q Xu","year":"2020","unstructured":"Xu Q, Zhou L, Yang G, Meng F, Wan Y, Wang L, Zhang L (2020) Overexpression of circ_0001445 decelerates hepatocellular carcinoma progression by regulating miR-942-5p\/ALX4 axis. Biotechnol Lett 42(12):2735\u20132747. https:\/\/doi.org\/10.1007\/s10529-020-02985-z","journal-title":"Biotechnol Lett"},{"issue":"17","key":"12624_CR35","doi-asserted-by":"publisher","first-page":"9881","DOI":"10.1111\/jcmm.15572","volume":"24","author":"S Ling","year":"2020","unstructured":"Ling S, He Y, Li X, Hu M, Ma Y, Li Y, Lu Z, Shen S, Kong B, Zou X, Jiang K, Huang P (2020) CircRHOT1 mediated cell proliferation, apoptosis and invasion of pancreatic cancer cells by sponging miR-125a-3p. J Cell Mol Med 24(17):9881\u20139889. https:\/\/doi.org\/10.1111\/jcmm.15572","journal-title":"J Cell Mol Med"},{"issue":"16","key":"12624_CR36","doi-asserted-by":"publisher","first-page":"20372","DOI":"10.18632\/aging.203417","volume":"13","author":"X Ren","year":"2021","unstructured":"Ren X, Yu J, Guo L, Ma H, Circular (2021) RNA circRHOT1 contributes to pathogenesis of non-small cell lung cancer by epigenetically enhancing C-MYC expression through recruiting KAT5. Aging 13(16):20372\u201320382. https:\/\/doi.org\/10.18632\/aging.203417","journal-title":"Aging"},{"key":"12624_CR37","doi-asserted-by":"publisher","first-page":"7608178","DOI":"10.1155\/2021\/7608178","volume":"2021","author":"H Ke","year":"2021","unstructured":"Ke H, Zhang J, Wang F, Xiong Y (2021) ZNF652-Induced circRHOT1 Promotes SMAD5 Expression to Modulate Tumorigenic Properties and Nature Killer Cell-Mediated Toxicity in Bladder Cancer via Targeting miR-3666. J Immunol Res 2021:7608178. https:\/\/doi.org\/10.1155\/2021\/7608178","journal-title":"J Immunol Res"},{"issue":"6","key":"12624_CR38","doi-asserted-by":"publisher","first-page":"8115","DOI":"10.18632\/aging.202608","volume":"13","author":"H Zhang","year":"2021","unstructured":"Zhang H, Ge Z, Wang Z, Gao Y, Wang Y, Qu X (2021b) Circular RNA RHOT1 promotes progression and inhibits ferroptosis via mir-106a-5p\/STAT3 axis in breast cancer. Aging 13(6):8115\u20138126. https:\/\/doi.org\/10.18632\/aging.202608","journal-title":"Aging"},{"issue":"4","key":"12624_CR39","doi-asserted-by":"publisher","first-page":"1715","DOI":"10.21037\/jgo-23-550","volume":"14","author":"H Wang","year":"2023","unstructured":"Wang H, Breadner DA, Deng K, Niu J (2023) CircRHOT1 restricts gastric cancer cell ferroptosis by epigenetically regulating GPX4. J Gastrointest Oncol 14(4):1715\u20131725. https:\/\/doi.org\/10.21037\/jgo-23-550","journal-title":"J Gastrointest Oncol"},{"issue":"6","key":"12624_CR40","doi-asserted-by":"publisher","first-page":"3222","DOI":"10.3390\/ijms23063222","volume":"23","author":"Y Miyachi","year":"2022","unstructured":"Miyachi Y, Miyazawa T, Ogawa Y (2022) HNF1A Mutations and Beta Cell Dysfunction in Diabetes. Int J Mol Sci 23(6):3222. https:\/\/doi.org\/10.3390\/ijms23063222","journal-title":"Int J Mol Sci"},{"issue":"11","key":"12624_CR41","doi-asserted-by":"publisher","first-page":"3543","DOI":"10.1111\/cas.13798","volume":"109","author":"Y Takashima","year":"2018","unstructured":"Takashima Y, Horisawa K, Udono M, Ohkawa Y, Suzuki A (2018) Prolonged inhibition of hepatocellular carcinoma cell proliferation by combinatorial expression of defined transcription factors. Cancer Sci 109(11):3543\u20133553. https:\/\/doi.org\/10.1111\/cas.13798","journal-title":"Cancer Sci"},{"issue":"6","key":"12624_CR42","doi-asserted-by":"publisher","first-page":"1922","DOI":"10.1097\/HEP.0000000000000466","volume":"78","author":"AG Singal","year":"2023","unstructured":"Singal AG, Llovet JM, Yarchoan M et al (2023) AASLD Practice Guidance on prevention, diagnosis, and treatment of hepatocellular carcinoma. Hepatology 78(6):1922\u20131965. https:\/\/doi.org\/10.1097\/HEP.0000000000000466","journal-title":"Hepatology"},{"issue":"1","key":"12624_CR43","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1053\/j.gastro.2009.04.005","volume":"137","author":"JA Marrero","year":"2009","unstructured":"Marrero JA, Feng Z, Wang Y et al (2009) Alpha-fetoprotein, des-gamma carboxyprothrombin, and lectin-bound alpha-fetoprotein in early hepatocellular carcinoma. Gastroenterology 137(1):110\u2013118. https:\/\/doi.org\/10.1053\/j.gastro.2009.04.005","journal-title":"Gastroenterology"},{"issue":"1","key":"12624_CR44","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1158\/1055-9965.EPI-13-0870","volume":"23","author":"PJ Johnson","year":"2014","unstructured":"Johnson PJ, Pirrie SJ, Cox TF et al (2014) The detection of hepatocellular carcinoma using a prospectively developed and validated model based on serological biomarkers. Cancer Epidemiol Biomarkers Prev 23(1):144\u2013153. https:\/\/doi.org\/10.1158\/1055-9965.EPI-13-0870","journal-title":"Cancer Epidemiol Biomarkers Prev"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-026-12624-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11033-026-12624-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-026-12624-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T11:10:51Z","timestamp":1787915451000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11033-026-12624-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,28]]},"references-count":44,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["12624"],"URL":"https:\/\/doi.org\/10.1007\/s11033-026-12624-x","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"value":"0301-4851","type":"print"},{"value":"1573-4978","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,28]]},"assertion":[{"value":"4 August 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"We have no conflict of interest to disclose.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was conducted in accordance with the ethical principles of the Declaration of Helsinki. This was done after receiving approval from Zagazig University\u2019s Institutional Review Board (IRB) for human studies and the local ethical council (reference number: ZU-IRB#1661\/9-Sep-2025). Written informed consent was obtained from all participants before sample collection.","order":2,"name":"Ethics","label":"Ethical Statment","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"1480"}}